KALA
KALA BIO, Inc.
Latest Form 4:Sale$27KbyReumuth Mary (CHIEF FINANCIAL OFFICER) · filed Oct 24, 2025
KALA BIO, Inc. (KALA) has 6 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Oct 24, 2025.
Insiders have net sold $1.3M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Avi Minkowitz
- Employees:6
- HQ:Arlington, MA, US
- IPO:2017-07-20
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Reumuth MaryFirst filing | CHIEF FINANCIAL OFFICER | Sale | 645 | $27K | Oct 24 | SEC ↗ |
Reumuth MaryFirst filing | CHIEF FINANCIAL OFFICER | Sale | 19 | $793 | Oct 24 | SEC ↗ |
Brazzell Romulus KFirst filing | SEE REMARKS | Sale | 935 | $39K | Oct 24 | SEC ↗ |
Iwicki Mark TFirst filing | Director | Sale | 3,098 | $125K | Oct 24 | SEC ↗ |
Bazemore ToddFirst filing | Director | Sale | 955 | $40K | Oct 24 | SEC ↗ |
Kharabi DariusFirst filing | CHIEF BUSINESS OFFICER | Sale | 416 | $17K | Oct 24 | SEC ↗ |
| Former 10% owner | Sale | 4,337 | $346K | Oct 2 | SEC ↗ | |
| Former 10% owner | Sale | 10,272 | $711K | Oct 2 | SEC ↗ |
Related companies
KALA BIO, Inc. is in the Healthcare sector.